Washinton Post: The Push to bring CBD to Medicare
The Washington Post Health Brief article describes a growing push to bring CBD treatments into Medicare through a planned federal pilot program, backed by a newly formed coalition of cannabis and health industry groups aiming to influence policy with research and patient data. The effort follows broader moves by the Trump administration to expand cannabis access and integrate hemp-derived therapies into mainstream healthcare, though it remains controversial due to limited FDA approval and questions around safety and efficacy. The article also references Constance Therapeutics as part of the industry ecosystem supporting these efforts—highlighting how certain manufacturers are positioning themselves as providers of clinically informed, cannabis-based treatments as policymakers explore whether CBD could become a reimbursable medical option for seniors.
